Advertisement

Topics

Companies Related to "Study Overturns Dogma Cancer Metabolism Theory" [Most Relevant Company Matches] RSS

05:09 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Study Overturns Dogma Cancer Metabolism Theory" found in our extensive corporate database of over 50,000 company records.

Showing "Study Overturns Dogma Cancer Metabolism Theory" Companies 1–25 of 3,100+

Relevant

Agios Pharmaceuticals, Inc.

Agios is the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Agios has multiple first-in-class programs in cancer metabolism and inborn errors of metabolism advancing toward the clinic, in addition to an active research and discovery pipeline across ...


Agios Pharmaceuticals

Agios Pharmaceuticals is the first biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging field of cancer metabolism. To support and drive these efforts, Agios is building a robust platform integrating cancer biology, metabolomics, biochemistry and informatics to enable target and biomarker identification...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.


International Society for the Study of Xenobiotics

Man's use of xenobiotics dates from antiquity but interest in foreign compound metabolism dates from only the mid-19th century when the knowledge and techniques of organic chemistry were first applied to its study. For nearly a century thereafter biotransformation was generally equated with "detoxication" or the elimination of a compound's biological activity.This view changed in the late 1930s wi...

Agios Pharmaceuticals , Inc.

Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class investigational m...

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

Raze Therapeutics

Raze Therapeutics is dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways essential to cancer growth and survival. By selectively targeting one-carbon (1C) metabolism using its proprietary platform, Raze is developing a pipeline of 1C metabolism therapeutics across a range of solid an...

Nagourney Cancer Institute

The Nagourney Cancer Institute is a clinical research center that has pioneered the study of human tumor tissue for individualized cancer patient drug selection and has facilitated cancer drug discovery.

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Numenta

Numenta scientists and engineers are working on one of science’s grand challenges: how the brain works and how brain principles will be used in Machine Intelligence. Founded in 2005, Numenta is developing a theory of how the neocortex works. We create software technologies based on this theory and apply them to machine learning applications for continuously ...

The German Breast Group and Celgene Corporation

GBG is a large independent academic network of over 500 study centers in Germany with the world- wide largest experience in conducting neoadjuvant breast cancer trials. Since 1998, with joined forces from AGO-B, over 10.000 patients participated in the neoadjuvant “Gepardo” trial series. GBG has recruited at totality of over 35.000 patients to tr...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

IOmet Pharma

IOmet Pharma Ltd is a privately-held drug discovery company based in Edinburgh, UK. Founded in 2008, IOmet is focused on the development of innovative medicines for the treatment of cancer, with particular emphasis on the fields of cancer immunotherapy and cancer metabolism. IOmet has a team with a proven track record of success in bringing small molecules...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

High-Q, Inc.

In theory, distillation is the most effective, most reliable, and least costly way to produce quality reagent-grade water on a laboratory scale. The challenge is to substantially narrow the gap between theory and practice and to design a still that takes full advantage of the distillation process and be truly automatic, self-cleaning, and self-sanitizing. Many years of intensive research and devel...

European Randomized Study of Screening for Prostate Cancer (ERSPC)

Austrian Breast & Colorectal Cancer Study Group (ABCSG)

ERSPC (European Randomized Study of Screening for Prostate Cancer)

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through Phase 1 human clinical trials ...

Pharmakin GmbH

Founded in 1987, Pharmakin has since then successfully provided competent bioanalysis and pharmacokinetic evaluation of new chemical entities, marketed drugs and their metabolites. Analysis is performed in GLP-certified laboratories by our highly qualified expert staff. State-of-the-art bioanalytical techniques are applied to all analytical procedures. Pharmakin’s services also include pharmacok...

American Asian Bio-Pharma Services, Inc

AA Bio-Pharma is a Clinical Research Organization (CRO) with US headquarters. It specializes in serving pharmaceutical, biotechnology, and medical device companies worldwide for pre-clinical and clinical studies in Asia, China. In the past years, AA Bio-Pharma with its partners in China has provided drug development services for sponsors around the world.Our services include:Pre-clinical Researc...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

The Institute for Integrative Psychotherapy

At our principal office and residential training facility in Kent, Connecticut (The Old Chestnut Inn), and on-site training institutes (in the mid-western U.S.A.; Vancouver, Canada; Europe; and South America) we offer a number of supervision groups, training programs, and intensive workshops for the practicing mental health professional.Based on the concepts and therapeutic methods developed by Ri...

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...

Spirogen and BioAtla

Spirogen Limited (“Spirogen”) was founded in 2001 as a spin-out from several institutions including University College, London. Since that time, it has developed a novel class of highly potent cytotoxic warheads based on its proprietary pyrrolobenzodiazepines (“PBD’s”), DNA minor groove binding agents, which bind and cross-link specific s...


More From BioPortfolio on "Study Overturns Dogma Cancer Metabolism Theory"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks